Company intelligence / Profile preview

Proteintech Group

Rosemont, Illinois, United Statesptglab.com ↗

Ownership: Private
Employees: ~450
Development stage: Commercial

Overview

Proteintech does not develop therapeutics or clinical candidates; instead it provides high-quality reagents—primarily antibodies and proteins—for life science research. Its products have been cited in over 310,000 publications worldwide and are widely used for basic and translational biomedical research[2][3].

Therapeutic areas: OncologyCardiovascularNeurologyInfectious Diseases
Modalities: AntibodyMonoclonal antibodyPolyclonal antibodyRecombinant proteinNanobody reagent
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Proteintech Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteintech Group.

Explore the full profile